A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma

Clinical trial NCT03722147 · COMPLETED

Trial details

NCT number: NCT03722147
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hodgkin's Lymphoma

Start date: 2018-08-13
Primary completion: 2020-01-10
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.